| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| May 11, 2026 | Buy(P) | 14K | $24.47 | $346K | 6.3M |
| May 11, 2026 | Buy(P) | 26K | $25.00 | $643K | 6.4M |
| May 8, 2026 | Buy(P) | 1K | $24.98 | $37K | 6.3M |
| May 7, 2026 | Buy(P) | 8K | $24.34 | $193K | 6.3M |
| May 7, 2026 | Buy(P) | 2K | $24.95 | $50K | 6.3M |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-26-000475) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Hemab Therapeutics Holdings, Inc.
This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/filing/0001231919-26-000475"
Use Arkolith to summarize insider buying and selling at Hemab Therapeutics Holdings, Inc. over the last 90 days and cite the filings.